Safety and Efficacy of Empagliflozin in GSD1b Patients With Neutropenia (EMPAtia)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04930627 |
|
Recruitment Status :
Not yet recruiting
First Posted : June 18, 2021
Last Update Posted : June 23, 2021
|
Sponsor:
Children's Memorial Health Institute, Poland
Collaborator:
Department of Internal Medicine, Hypertension and Vascular Diseases, The Medical University of Warsaw
Information provided by (Responsible Party):
Dariusz Rokicki, Children's Memorial Health Institute, Poland
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Not yet recruiting |
|---|---|
| Estimated Primary Completion Date : | June 2024 |
| Estimated Study Completion Date : | March 2025 |